Dr. Burton on the need for longer-term studies on Aquablation for LUTS
"Right now, the longest-term studies are the WATER trials, which have published 5-year outcomes. But we know that a subset of men will require retreatment over time," says Claire S. Burton, MD.
In this video, Claire S. Burton, MD, discusses further research needed from the study, “Outcomes of Aquablation in men with acute and chronic urinary retention,” for which she served as the lead author. Burton is an FPMRS fellow at Standford University in California.
Video Transcript:
I think what we continue to need is longer term follow-up. Right now, the longest-term studies are the WATER trials, which have published 5-year outcomes. But we know that a subset of men will require retreatment over time, and so I think longer follow-up. In our sample, the mean follow-up was 6 months. We know that some men will need to go back on prostate medications or will need to have retreatment over time and our follow-up is likely too short to reflect those long-term differences. We did find that less than 10% of our patients went back on prostate medication use at their time of follow-up, which was pretty consistent with what was in the WATER trials and also what we expect in the TURP literature as well.
This transcription has been edited for clarity.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Researchers advocate ultrasound over CT for initial evaluation of suspected urinary stone disease
November 7th 2022The study authors maintain there is no current evidence in the literature indicating that CT use is superior to other imaging modalities in reducing morbidity or improving outcomes in patients with urinary stone disease.
